News Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer Continue Reading Previous APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF)Next EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023 Related Stories News A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today News U.S. Polo Assn. Celebrates Seventh Year Supporting the 2025 Outsourcing Inc. Royal Charity Polo Cup News Formerra to Supply Foster Medical Compounds Across the Americas News Ocean One Seizing Business Opportunities with Main Board Listing Application News Imagen Network Embeds XRP Architecture to Enable Faster Peer Engagement Through AI Filters News Beyond Medical Technologies Announces Corporate Name Change to Republic Technologies
